Jump to content

Bharat Biotech: Difference between revisions

From Wikipedia, the free encyclopedia
Browse history interactively
← Previous editNext edit →
Content deleted Content added
VisualWikitext
No edit summary
Tags: Mobile edit Mobile web edit Advanced mobile edit
No edit summary
Tags: Mobile edit Mobile web edit Advanced mobile edit
Line 19: Line 19:
}}
}}


'''Bharat Biotech International Limited''' is a [[Biotechnology]] company headquartered in [[Hyderabad]], [[India]] engaged in manufacture of [[vaccines]], bio-therapeutics and health care products.<ref name="bloomberg">{{cite web |title=Bharat Biotech International Ltd |url=https://www.bloomberg.com/profile/company/7535940Z:IN |website=www.bloomberg.com |accessdate=3 July 2020}}</ref>
'''Bharat Biotech International Limited''' is a [[Pharmaceuticals]] company headquartered in [[Hyderabad]], [[India]] engaged in manufacture of [[vaccines]], bio-therapeutics and health care products.<ref name="bloomberg">{{cite web |title=Bharat Biotech International Ltd |url=https://www.bloomberg.com/profile/company/7535940Z:IN |website=www.bloomberg.com |accessdate=3 July 2020}}</ref>


==Overview==
==Overview==

Revision as of 11:42, 7 July 2020

Bharat Biotech International Limited
Company typePrivate Limited Company
IndustryPharmaceuticals
Founded1996
HeadquartersHyderabad, India
Key people
Dr. Krishna M. Ella
ProductsROTAVAC[1], TypbarTCV[2], Biopolio, Comvac and JENVAC
SubsidiariesChiron Behring Vaccines [3]
Websitewww.bharatbiotech.com

Bharat Biotech International Limited is a Pharmaceuticals company headquartered in Hyderabad, India engaged in manufacture of vaccines, bio-therapeutics and health care products.[4]

Overview

Bharat Biotech has its manufacturing facility situated at Genome Valley, Hyderabad, India.[4] Currently, the company employs over 700 employees[5] and has a presence worldwide.[4]

The company has been responsible for developing an eco-friendly recombinant[6] and a naturally attenuated strain derived Rotavirus vaccine called ROTAVAC[7][8] They were one of the first to develop vaccines for viral diseases like Chikungunya[9][10] and Zika.[11][12]. The company also produces vaccines for Japanese Encephalitis.[13]

COVID-19 vaccine development

In April 2020, the company announced that they have partnered with US-based company FluGen and University of Wisconsin-Madison to develop a COVID-19 vaccine.[14][15]

In May 2020, ICMR - National Institute of Virology approved and provided the virus strains for developing a fully indigenous COVID-19 vaccine.[16][17]. On June 29, the company got permission to conduct Phase 1 and Phase 2 human trials of developmental COVID-19 vaccine named Covaxin, from DCGI, Government of India.[18][19][20][21]

See also

Reference

  1. ^ "WHO prequalifies new rotavirus vaccine". WHO. Retrieved 2 July 2020.
  2. ^ "WHO recommends use of first typhoid conjugate vaccine". WHO. Retrieved 2 July 2020.
  3. ^ Bureau, Our. "Bharat Biotech buys Chiron Behring Vaccines from GSK". The Hindu BusinessLine. Retrieved 1 July 2020.
  4. ^ a b c "Bharat Biotech International Ltd". www.bloomberg.com. Retrieved 3 July 2020.
  5. ^ "Leading Biotech Vaccine Manufacturers in India - Bharat Biotech". www.bharatbiotech.com. Retrieved 30 June 2020.
  6. ^ "Process for the preparation and purification of recombinant proteins". patents.google.com. US patent No US8956812B2. 23 August 2004.
  7. ^ Bhandari, Nita; Rongsen-Chandola, Temsunaro; Bavdekar, Ashish; John, Jacob; Antony, Kalpana; Taneja, Sunita; Goyal, Nidhi; Kawade, Anand; Kang, Gagandeep; Rathore, Sudeep Singh; Juvekar, Sanjay; Muliyil, Jayaprakash; Arya, Alok; Shaikh, Hanif; Abraham, Vinod; Vrati, Sudhanshu; Proschan, Michael; Kohberger, Robert; Thiry, Georges; Glass, Roger; Greenberg, Harry B; Curlin, George; Mohan, Krishna; Harshavardhan, G V J A; Prasad, Sai; Rao, T S; Boslego, John; Bhan, Maharaj Kishan (June 2014). "Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial". The Lancet. 383 (9935): 2136–2143. doi:10.1016/S0140-6736(13)62630-6. PMC 4532697. PMID 24629994.
  8. ^ Kang, G (October 2006). "Rotavirus vaccines". Indian Journal of Medical Microbiology. 24 (4): 252–7. doi:10.4103/0255-0857.29382. PMC 2481304. PMID 17185842.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  9. ^ "Bharat Biotech's Zika, Chikungunya vaccines to enter Phase II trials; focus now on private label market". Moneycontrol.
  10. ^ "CEPI, 치쿤구니아 백신 개발 위해 국제백신연구소-바라트 바이오텍 컨소시엄에 최대 1410만달러 지원". CEPI, 치쿤구니아 백신 개발 위해 국제백신연구소-바라트 바이오텍 컨소시엄에 최대 1410만달러 지원 - 뉴스와이어 (in Korean). 3 June 2020.
  11. ^ "Bharat Biotech gets breakthrough in developing Zika vaccine". The Economic Times. 4 February 2016.
  12. ^ "CEPI awards up to US$14.1million to consortium of IVI and Bharat Biotech to advance development of Chikungunya vaccine in collaboration with Ind-CEPI – IVI". www.ivi.int. International Vaccine Institute. Retrieved 30 June 2020.
  13. ^ Singh, Anit; Mitra, Monjori; Sampath, Gadey; Venugopal, P.; Rao, J. Venkateswara; Krishnamurthy, B.; Gupta, Mukesh Kumar; Sri Krishna, S.; Sudhakar, B.; Rao, N. Bhuvaneswara; Kaushik, Yashpal; Gopinathan, K.; Hegde, Nagendra R.; Gore, Milind M.; Krishna Mohan, V.; Ella, Krishna M. (1 September 2015). "A Japanese Encephalitis Vaccine From India Induces Durable and Cross-protective Immunity Against Temporally and Spatially Wide-ranging Global Field Strains". Journal of Infectious Diseases. 212 (5): 715–725. doi:10.1093/infdis/jiv023. PMID 25601942.
  14. ^ "UW-Madison, Flugen, Bharat Biotech to develop coroflu, a coronavirus vaccine". Global Health Institute. Retrieved 30 June 2020.
  15. ^ "Bharat Biotech ties up with US varsity for Covid vaccine". Hindustan Times. 20 May 2020.
  16. ^ "ICMR teams up with Bharat Biotech to develop Covid-19 vaccine". Livemint. 9 May 2020.
  17. ^ Chakrabarti, Angana (10 May 2020). "India to develop 'fully indigenous' Covid vaccine as ICMR partners with Bharat Biotech". ThePrint.
  18. ^ "India's First COVID-19 Vaccine Candidate Approved for Human Trials". The New York Times. 29 June 2020.
  19. ^ "Human trial of India coronavirus vaccine announced". BBC News. 30 June 2020.
  20. ^ "Bharat Biotech's Covid vaccine 1st in India to get approval for human trials". The Indian Express. 30 June 2020.
  21. ^ "Covaxin: India's first COVID19 vaccine candidate from Bharat Biotech to begin human trials; check details". The Financial Express. 30 June 2020.

External links

Retrieved from "https://en.wikipedia.org/w/index.php?title=Bharat_Biotech&oldid=966488424"